For following the competition: what moved in each program, several studies read as one move.
- dersimelagon
- BK1803
- BRD4 Degrader MT-4561
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Tanabe Pharma to watchlistEvery Monday by email · turn it off any timePro · free during the beta